The largest database of trusted experimental protocols

Ecl reagent

Manufactured by Takara Bio
Sourced in Japan, United Kingdom

ECL reagent is a chemiluminescent detection solution used for Western blotting analysis. It is designed to detect and visualize target proteins labeled with horseradish peroxidase (HRP) conjugates.

Automatically generated - may contain errors

2 protocols using ecl reagent

1

Western Blot Protocol for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After SDS-PAGE separation of proteins, transfer sandwich was prepared with PVDF membrane and placed in transfer buffer. PVDF membrane (Amersham) was activated with methanol for 15 s prior to use. The blot was allowed to run for 120 min at 100 volts. After the transfer of proteins, membrane was blocked using 5% skimmed milk powder as blocking buffer for 1 h at RT. Then membrane was washed with 1× TBST buffer and incubated with primary antibody overnight (details of antibody in Supplementary Table 3). Again, membrane was washed in 1× TBST buffer followed by secondary antibody (1:5,000 dilution) treatment, then incubated for 1 h at RT. After incubation, membrane was washed with 1× TBST buffer three times and detected with ECL reagent (TAKARA, Japan) using Versa Doc (BD Bioscience, USA) or X-ray film.
+ Open protocol
+ Expand
2

Nuclear Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclear extracts were prepared from livers or hepatocytes using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) according to the manufacture's protocol. Nuclear extracts were mixed with SDS sample loading buffer (Wako Pure Chemical Corporation, Osaka, Japan), electrophoresed using a Super-Sep TM Ace 10% gel (Wako Pure Chemical Corporation), and then electrotransferred onto an Immobilon-P membrane (Millipore, Billerica, MA). The membrane was blocked overnight in phosphate buffered saline (PBS) with Tween 20 (PBS-T) containing 3% or 5% Amersham TM ECL TM Blocking Agent (GE healthcare UK Ltd.) and then incubated with primary antibody-Bcl6 antibody (D-8; Santa Cruz Biotechnology, Dallas, TX)-for 2 h. Next, the membrane was washed with PBS-T and incubated with horseradish peroxidase-conjugated secondary antibody (Millipore). During incubation with primary and secondary antibodies, western blot immune booster solutions (Takara Bio Inc., Shiga, Japan) were used to enhance antibody interactions. After another wash with PBS-T, immunoreactive proteins were developed by the ECL reagent (Takara Bio Inc.) and chemiluminescence was captured using the Image Quant LAS 500 (GE healthcare UK Ltd.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!